Cargando…
Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
BACKGROUND: Cumulative evidence in colorectal cancer (CRC) suggests that patients with human epidermal growth factor receptor 2 (HER2) overexpression or amplification can benefit from anti-HER2 therapy. The purpose of our study was to evaluate HER2 status and its correlation with clinicopathological...
Autores principales: | Ni, Shujuan, Wang, Xin, Chang, Jinjia, Sun, Hui, Weng, Weiwei, Wang, Xu, Tan, Cong, Zhang, Meng, Wang, Lei, Huang, Zhaohui, Huang, Dan, Xu, Midie, Sheng, Weiqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097912/ https://www.ncbi.nlm.nih.gov/pubmed/35574415 http://dx.doi.org/10.3389/fonc.2022.842787 |
Ejemplares similares
-
CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018) -
Pathological risk factors for lymph node metastasis in patients with submucosal invasive colorectal carcinoma
por: Zhang, Qiongyan, et al.
Publicado: (2019) -
Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022) -
miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA
por: Ni, Shujuan, et al.
Publicado: (2018) -
Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases
por: Ren, Fei, et al.
Publicado: (2019)